Shopping Cart 0
Cart Subtotal
USD 0

Taconic Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Taconic Biosciences Inc (Taconic), formerly Taconic Farms Inc is a research model provider that offers animal health models and laboratory services. The company's products include taconic transgenic mouse models, emerging models, cryopreserved models, traditional models, diet induced obese, traditional models, diet induced obese, Alzheimer disease models, neuropsychiatric disorder models and Parkinson disease models. It offers GEM collection, xenoreceptor panel, cytochrome P450 panel and transporter panel. Taconic offers services such as consultancy, compound administration and tissue extraction. The company also offers monoclonal antibody production, genotyping services, animal health testing, surgical procedures and modifications. It operates offices in the US, Germany and Denmark. Taconic is headquartered in Rensselaer, New York, the US.

Taconic Biosciences Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Taconic Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Taconic Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Taconic Biosciences Enters into Agreement with Cergentis 11

Taconic Biosciences Enters into Agreement with Pharmatest 12

Taconic Biosciences Enters into Co-Marketing Agreement with Life Technologies 13

Taconic Biosciences Enters into Agreement with Cellaria Biosciences 14

Taconic Biosciences Expands Distribution Agreement with CLEA Japan 15

MJFF, Jefferson And Taconic Enter Into Co-Development Agreement 16

Taconic Farms Enters Into Agreement With Medicyte To Promote Upycte Hepatocyte Products 17

Licensing Agreements 18

Taconic Biosciences Enters into Licensing Agreement with University of Nebraska 18

Taconic Enters Into Licensing Agreement With InnoSer 19

Taconic Biosciences Inc-Key Competitors 20

Taconic Biosciences Inc-Key Employees 21

Taconic Biosciences Inc-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 24

Strategy And Business Planning 24

May 03, 2017: Taconic Biosciences Announces Expansion of Key Alzheimer Animal Model 24

Jan 12, 2017: Taconic Biosciences Expands European Immunodeficient Animal Production 25

Corporate Communications 26

Feb 21, 2018: Taconic Biosciences Announces the Formation of Scientific Advisory Board 26

Product News 27

Dec 15, 2017: Protective Efficacy of Influenza Group 2 Hemagglutinin Stem-fragment Immunogen Vaccines 27

Jun 13, 2018: Taconic Biosciences Launches European Production of Diet Induced Obesity Model 28

Apr 25, 2017: Taconic Biosciences Announces Release of New Parkinson's Disease Animal Model 29

Apr 19, 2018: Taconic Biosciences Launches New Inflammatory Bowel Disease Models 30

Feb 17, 2017: Taconic Biosciences Generates Vici Syndrome Mouse Model 31

Other Significant Developments 32

Sep 20, 2018: Taconic biosciences becomes the first animal model provider on general services administration contract schedule 32

Apr 20, 2018: Taconic Biosciences Launches New Models for Bowel's Inflammatory Disease 33

May 04, 2017: Taconic Biosciences Expands Microbiome Portfolio 34

Apr 26, 2017: Taconic Biosciences Expands Microbiome Product and Service Platform 35

Apr 03, 2017: Taconic Biosciences Launches ExpressMODEL, a New Accelerated Model Generation Service 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37


List Of Figure

List of Figures

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Taconic Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts 2

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Taconic Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Taconic Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Taconic Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Taconic Biosciences Enters into Agreement with Cergentis 11

Taconic Biosciences Enters into Agreement with Pharmatest 12

Taconic Biosciences Enters into Co-Marketing Agreement with Life Technologies 13

Taconic Biosciences Enters into Agreement with Cellaria Biosciences 14

Taconic Biosciences Expands Distribution Agreement with CLEA Japan 15

MJFF, Jefferson And Taconic Enter Into Co-Development Agreement 16

Taconic Farms Enters Into Agreement With Medicyte To Promote Upycte Hepatocyte Products 17

Taconic Biosciences Enters into Licensing Agreement with University of Nebraska 18

Taconic Enters Into Licensing Agreement With InnoSer 19

Taconic Biosciences Inc, Key Competitors 20

Taconic Biosciences Inc, Key Employees 21

Taconic Biosciences Inc, Other Locations 22

Taconic Biosciences Inc, Subsidiaries 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Taconic Biosciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Taconic Biosciences Inc (Taconic), formerly Taconic Farms Inc is a research model provider that offers animal health models and laboratory services. The company's products include taconic transgenic mouse models, emerging models, cryopreserved models, traditional models, diet induced obese, traditional models, diet induced obese, Alzheimer disease models, neuropsychiatric disorder models and Parkinson disease models. It offers GEM collection, xenoreceptor panel, cytochrome P450 panel and transporter panel. Taconic offers services such as consultancy, compound administration and tissue extraction. The company also offers monoclonal antibody production, genotyping services, animal health testing, surgical procedures and modifications. It operates offices in the US, Germany and Denmark. Taconic is headquartered in Rensselaer, New York, the US.

Taconic Biosciences Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Taconic Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Taconic Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Taconic Biosciences Enters into Agreement with Cergentis 11

Taconic Biosciences Enters into Agreement with Pharmatest 12

Taconic Biosciences Enters into Co-Marketing Agreement with Life Technologies 13

Taconic Biosciences Enters into Agreement with Cellaria Biosciences 14

Taconic Biosciences Expands Distribution Agreement with CLEA Japan 15

MJFF, Jefferson And Taconic Enter Into Co-Development Agreement 16

Taconic Farms Enters Into Agreement With Medicyte To Promote Upycte Hepatocyte Products 17

Licensing Agreements 18

Taconic Biosciences Enters into Licensing Agreement with University of Nebraska 18

Taconic Enters Into Licensing Agreement With InnoSer 19

Taconic Biosciences Inc-Key Competitors 20

Taconic Biosciences Inc-Key Employees 21

Taconic Biosciences Inc-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 24

Strategy And Business Planning 24

May 03, 2017: Taconic Biosciences Announces Expansion of Key Alzheimer Animal Model 24

Jan 12, 2017: Taconic Biosciences Expands European Immunodeficient Animal Production 25

Corporate Communications 26

Feb 21, 2018: Taconic Biosciences Announces the Formation of Scientific Advisory Board 26

Product News 27

Dec 15, 2017: Protective Efficacy of Influenza Group 2 Hemagglutinin Stem-fragment Immunogen Vaccines 27

Jun 13, 2018: Taconic Biosciences Launches European Production of Diet Induced Obesity Model 28

Apr 25, 2017: Taconic Biosciences Announces Release of New Parkinson's Disease Animal Model 29

Apr 19, 2018: Taconic Biosciences Launches New Inflammatory Bowel Disease Models 30

Feb 17, 2017: Taconic Biosciences Generates Vici Syndrome Mouse Model 31

Other Significant Developments 32

Sep 20, 2018: Taconic biosciences becomes the first animal model provider on general services administration contract schedule 32

Apr 20, 2018: Taconic Biosciences Launches New Models for Bowel's Inflammatory Disease 33

May 04, 2017: Taconic Biosciences Expands Microbiome Portfolio 34

Apr 26, 2017: Taconic Biosciences Expands Microbiome Product and Service Platform 35

Apr 03, 2017: Taconic Biosciences Launches ExpressMODEL, a New Accelerated Model Generation Service 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37


List Of Figure

List of Figures

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Taconic Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts 2

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Taconic Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Taconic Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Taconic Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

Taconic Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Taconic Biosciences Enters into Agreement with Cergentis 11

Taconic Biosciences Enters into Agreement with Pharmatest 12

Taconic Biosciences Enters into Co-Marketing Agreement with Life Technologies 13

Taconic Biosciences Enters into Agreement with Cellaria Biosciences 14

Taconic Biosciences Expands Distribution Agreement with CLEA Japan 15

MJFF, Jefferson And Taconic Enter Into Co-Development Agreement 16

Taconic Farms Enters Into Agreement With Medicyte To Promote Upycte Hepatocyte Products 17

Taconic Biosciences Enters into Licensing Agreement with University of Nebraska 18

Taconic Enters Into Licensing Agreement With InnoSer 19

Taconic Biosciences Inc, Key Competitors 20

Taconic Biosciences Inc, Key Employees 21

Taconic Biosciences Inc, Other Locations 22

Taconic Biosciences Inc, Subsidiaries 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Taconic Biosciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.